Literature DB >> 10673359

Tumor antigen HuR binds specifically to one of five protein-binding segments in the 3'-untranslated region of the neurofibromin messenger RNA.

J Haeussler1, J Haeusler, A M Striebel, G Assum, W Vogel, H Furneaux, W Krone.   

Abstract

3'-untranslated regions of various mRNAs have been shown to contain sequence motifs which control mRNA stability, translatability, and efficiency of translation as well as intracellular localization. We aimed to identify protein binding regions of the long and highly conserved 3'UTR of the mRNA coding for neurofibromin, a well-known tumor suppressor protein, whose genetic deficiency causes the autosomal dominant disease neurofibromatosis type 1 (NF1). We discovered five RNA fragments that were able to undergo specific binding to proteins from cell lysates (NF1-PBRs, NF1-protein-binding regions). Additionally we identified the Elav-like protein HuR binding to NF1-PBR1. HuR interacts with AU-rich elements in the 3'UTR of many protooncogenes, cytokines, and transcription factors, thereby regulating the expression of these mRNAs on the posttranscriptional level. Transfection assays with a CAT reporter construct revealed reduced expression of the reporter, suggesting that HuR may be involved in the fine-tuning of the expression of the NF1 gene. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673359     DOI: 10.1006/bbrc.1999.2019

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Posttranscriptional regulation of gene expression in learning by the neuronal ELAV-like mRNA-stabilizing proteins.

Authors:  A Quattrone; A Pascale; X Nogues; W Zhao; P Gusev; A Pacini; D L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

Review 2.  MRNA stability and the control of gene expression: implications for human disease.

Authors:  Elysia M Hollams; Keith M Giles; Andrew M Thomson; Peter J Leedman
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

3.  Differential expression of duplicated opsin genes in two eyetypes of ostracod crustaceans.

Authors:  Todd H Oakley; Daniel R Huber
Journal:  J Mol Evol       Date:  2004-08       Impact factor: 2.395

4.  HuD binds to three AU-rich sequences in the 3'-UTR of neuroserpin mRNA and promotes the accumulation of neuroserpin mRNA and protein.

Authors:  Ana Cuadrado; Cristina Navarro-Yubero; Henry Furneaux; Jochen Kinter; Peter Sonderegger; Alberto Muñoz
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

Review 5.  The pathoetiology of neurofibromatosis 1.

Authors:  Eeva-Mari Jouhilahti; Sirkku Peltonen; Anthony M Heape; Juha Peltonen
Journal:  Am J Pathol       Date:  2011-03-31       Impact factor: 4.307

Review 6.  Hu Antigen R (HuR) Protein Structure, Function and Regulation in Hepatobiliary Tumors.

Authors:  Sofia Lachiondo-Ortega; Teresa Cardoso Delgado; Blanca Baños-Jaime; Alejandro Velázquez-Cruz; Irene Díaz-Moreno; María Luz Martínez-Chantar
Journal:  Cancers (Basel)       Date:  2022-05-27       Impact factor: 6.575

Review 7.  Diverse molecular functions of Hu proteins.

Authors:  M N Hinman; H Lou
Journal:  Cell Mol Life Sci       Date:  2008-10       Impact factor: 9.261

Review 8.  Understanding and targeting the disease-related RNA binding protein human antigen R (HuR).

Authors:  Christopher W Schultz; Ranjan Preet; Teena Dhir; Dan A Dixon; Jonathan R Brody
Journal:  Wiley Interdiscip Rev RNA       Date:  2020-01-23       Impact factor: 9.957

Review 9.  HuR function in disease.

Authors:  Subramanya Srikantan; Myriam Gorospe
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

10.  miR-107 regulates tumor progression by targeting NF1 in gastric cancer.

Authors:  Shizhi Wang; Gaoxiang Ma; Haixia Zhu; Chunye Lv; Haiyan Chu; Na Tong; Dongmei Wu; Fulin Qiang; Weida Gong; Qinghong Zhao; Guoquan Tao; Jianwei Zhou; Zhengdong Zhang; Meilin Wang
Journal:  Sci Rep       Date:  2016-11-09       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.